Challenges to National Cancer Institute-Supported Cooperative Group Clinical Trial Participation: An ASCO Survey of Cooperative Group Sites

Allison R Baer; Chelsey A Kelly; Suanna S Bruinooge; Carolyn D Runowicz; Douglas W Blayney

doi:10.1200/JOP.200028

Challenges to National Cancer Institute-Supported Cooperative Group Clinical Trial Participation: An ASCO Survey of Cooperative Group Sites

J Oncol Pract. 2010 May;6(3):114-7. doi: 10.1200/JOP.200028. Epub 2010 Apr 15.

Authors

Allison R Baer¹, Chelsey A Kelly, Suanna S Bruinooge, Carolyn D Runowicz, Douglas W Blayney

Affiliation

¹ American Society of Clinical Oncology, Alexandria, VA; Neag Comprehensive Cancer Center, University of Connecticut Heath Center, Farmington, CT; and Department of Internal Medicine, University of Michigan School of Medicine, Ann Arbor, MI.

Abstract

Anecdotal information regarding clinical research sites limiting participation in NCI-funded cooperative group studies prompted ASCO to collect data on and investigate the reasons behind this trend.